Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication

被引：15
|
作者：
Silverman, Stuart [1 ,2 ,3 ]
Kupperman, Eli [4 ]
Bukata, Susan [5 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] OMC Clin Res Ctr, Beverly Hills, CA USA
[3] UCLA, David Geffen Sch Med, Med, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA
[5] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2018年 / 85卷 / 11期
关键词：
FEMUR FRACTURES; SHAFT FRACTURES; HIP FRACTURE; OLDER-ADULTS; RISK; WOMEN; MORTALITY; OUTCOMES; THERAPY; ALENDRONATE;
D O I：
10.3949/ccjm.85a.17119
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atypical femoral fracture is a rare but serious complication of long-term bisphosphonate therapy. Although the benefit of preventing osteoporotic fractures greatly outweighs the risk of atypical fracture in bisphosphonate users, concern about atypical fracture risk has led to a decrease in bisphosphonate use. What are the risks, and how do we treat atypical femoral fracture?
引用
收藏
页码：885 / 893
页数：9
相关论文
共 50 条
  • [31] Bisphosphonate-related jaw necrosis - Severe complication in maxillofacial surgery
    Eckert, A. W.
    Maurer, P.
    Meyer, L.
    Kriwalsky, M. S.
    Rohrberg, R.
    Schneider, D.
    Bilkenroth, U.
    Schubert, J.
    CANCER TREATMENT REVIEWS, 2007, 33 (01) : 58 - 63
  • [32] Atypical femoral fractures related to bisphosphonate treatment
    Koh, A.
    Guerado, E.
    Giannoudis, P. V.
    BONE & JOINT JOURNAL, 2017, 99B (03): : 295 - 302
  • [33] Atypical femoral fractures: a complication of prolonged bisphosphonate therapy? REPLY
    Girgis, Christian M.
    Seibel, Markus J.
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (02) : 103 - 103
  • [34] Is Atypical Bisphosphonate Treatment Response a Risk Factor for Atypical Femoral Fracture?
    Troy, Karen L.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2017, 99 (19):
  • [35] Do bisphosphonate-related atypical femoral fractures and osteonecrosis of the jaw affect the same group of patients? A pilot study
    Afif, Haitham
    Mukka, Sebastian
    Sjoden, Goeran
    Sayed-Noor, Arkan S.
    ORTHOPEDIC REVIEWS, 2014, 6 (01) : 4 - 6
  • [36] Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw
    Kharazmi, Mohammad
    Hallberg, Par
    Michaelsson, Karl
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (08) : 1594 - 1594
  • [37] Bisphosphonate-Related Atypical Femoral Fractures in Patients with Autoimmune Disease Treated with Glucocorticoids: Surgical Results for 20 Limbs
    Nishino, Tomofumi
    Hyodo, Kojiro
    Matsumoto, Yukei
    Yanagisawa, Yohei
    Yamazaki, Masashi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [38] Prophylactic Intramedullary Fixation for Bisphosphonate-related Subtrochanteric Stress Fracture
    Fowler, John R.
    Criner, Katharine
    Craig, Matthew R.
    ORTHOPEDICS, 2012, 35 (06) : E954 - E957
  • [39] CONCOMITANT ATYPICAL FEMORAL FRACTURE AND OSTEONECROSIS OF THE JAW IN BISPHOSPHONATE USERS
    Correa-Perez, A.
    Sanchez-Castellanos, C.
    Cruz-Jentoft, A. J.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S328 - S328
  • [40] An Incomplete Atypical Femoral Fracture Associated with Bisphosphonate Therapy and Femoral Skeletal Metastasis
    Taxel, Pamela
    Lindsay, Adam
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 140 - 140
12345